Table 5

Persistence of lipid-induced apoptosis in the presence of SB-203580

TreatmentControlSB-203580SKF-105209
%
Vehicle3  ± 14  ± 12  ± 1
Ceramide51  ± 75-a 53  ± 25-a 49  ± 65-a
Sphingosine73  ± 65-a 70  ± 55-a 77  ± 45-a

U937 cells were exposed to ceramide (10 μm) or sphingosine (10 μm) for 6 hr in the absence or presence of the selective pharmacological p38-RK inhibitor SB-213580 or the inactive analog SKF-105209. The fraction of cells exhibiting cytological evidence of apoptotic DNA damage was then determined by fluorescence microscopy as described in Materials and Methods; all values are expressed as the percentage of apoptotic cells within the total scored for a given treatment.

    • 5-a Increased vs.vehicle-treated controls (p < 0.01).